… As the coronavirus disease (COVID-19) pandemic led to a global health crisis, there were
… acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma is quick to …

… published its guidance document for investigational COVID-19 convalescent plasma (25).
The document outlines three pathways for access to convalescent plasma. The first is under …

… of the coronavirus disease 2019 (COVID-19) pandemic. … Convalescent plasma (CP) constitutes
the first option in the … and their repercussion in COVID-19 pathogenesis, including direct …

… According to WHO,13 management of COVID-19 has mainly … of COVID-19, which was also
the recommendation in aa Commnt in The Lancet.Evidence shows that convalescent plasma …

… in 5000 patients transfused with COVID-19 convalescent plasma showed an incidence of …
transfusion of convalescent plasma is safe in hospitalized adults with COVID-19. Because …

… for COVID-19 are rather limited. To evaluate the efficacy of convalescent plasma therapy
in COVID-19 … Six laboratory-confirmed COVID-19 patients were enrolled and received the …

… the rapidly increasing number of COVID-19 cases provides an unprecedented … convalescent
plasma and H-Ig in a complementary way to treat infected patients in the current COVID-19 …

… from COVID-19, most patients have anti-SARS-CoV-2 neutralizing antibodies. Their
convalescent plasma could be an inexpensive and widely available treatment for COVID-19. …

Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …

… Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the
number of COVID-19 … pneumonia suggest that convalescent plasma can reduce mortality, …